REDWOOD CITY, Calif.--(BUSINESS WIRE)--Genelabs Technologies, Inc. (Nasdaq:GNLB), a biopharmaceutical company focused on discovering novel compounds for hepatitis, announced today that Amy K. Patick, Ph.D. has been appointed Vice President, Biological Sciences.
